Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Buy
63
GVDNY Quote, Financials, Valuation and Earnings
Last price:
$88.08
Seasonality move
:
3.44%
Day range:
$87.06 - $88.33
52-week range:
$75.55 - $110.32
Dividend yield:
1.71%
P/E ratio:
35.43x
P/S ratio:
5.13x
P/B ratio:
8.47x
Volume:
47K
Avg. volume:
33K
1-year change:
9.65%
Market cap:
$40.6B
Revenue:
$7.7B
EPS (TTM):
$2.49
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
GVDNY
Givaudan SA
|
-- | -- | -- | -- | -- |
|
BCHMY
Bachem Holding AG
|
-- | -- | -- | -- | -- |
|
CLZNY
Clariant AG
|
$1.2B | -- | -- | -- | -- |
|
EMSHF
Ems-Chemie Holding AG
|
-- | -- | -- | -- | -- |
|
HCMLY
Holcim
|
-- | -- | -- | -- | -- |
|
SXYAY
Sika AG
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
GVDNY
Givaudan SA
|
$88.08 | -- | $40.6B | 35.43x | $1.50 | 1.71% | 5.13x |
|
BCHMY
Bachem Holding AG
|
$6.47 | -- | $4.9B | 38.15x | $0.04 | 1.35% | 7.52x |
|
CLZNY
Clariant AG
|
$12.38 | -- | $4.1B | 45.64x | $0.47 | 3.8% | 0.88x |
|
EMSHF
Ems-Chemie Holding AG
|
$703.72 | -- | $16.5B | 31.96x | $18.49 | 2.09% | 7.04x |
|
HCMLY
Holcim
|
$19.26 | -- | $54.1B | 16.15x | $0.62 | 3.21% | 1.82x |
|
SXYAY
Sika AG
|
$23.80 | -- | $38.2B | 27.83x | $0.36 | 1.53% | 2.93x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
GVDNY
Givaudan SA
|
53.25% | 1.034 | 12.51% | 0.84x |
|
BCHMY
Bachem Holding AG
|
-- | 1.067 | -- | 1.57x |
|
CLZNY
Clariant AG
|
45.79% | -1.031 | 38.27% | 0.79x |
|
EMSHF
Ems-Chemie Holding AG
|
-- | 0.259 | -- | 2.39x |
|
HCMLY
Holcim
|
-- | 1.293 | -- | 0.79x |
|
SXYAY
Sika AG
|
48.29% | 1.407 | 14.55% | 1.00x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
GVDNY
Givaudan SA
|
-- | -- | 11.36% | 24.76% | -- | -- |
|
BCHMY
Bachem Holding AG
|
-- | -- | 8.65% | 8.65% | -- | -- |
|
CLZNY
Clariant AG
|
-- | -- | 2.13% | 3.32% | -- | -- |
|
EMSHF
Ems-Chemie Holding AG
|
-- | -- | 23.16% | 23.25% | -- | -- |
|
HCMLY
Holcim
|
-- | -- | 9.38% | 10.97% | -- | -- |
|
SXYAY
Sika AG
|
-- | -- | 9.98% | 21.13% | -- | -- |
Givaudan SA vs. Competitors
-
Which has Higher Returns GVDNY or BCHMY?
Bachem Holding AG has a net margin of -- compared to Givaudan SA's net margin of --. Givaudan SA's return on equity of 24.76% beat Bachem Holding AG's return on equity of 8.65%.
Company Gross Margin Earnings Per Share Invested Capital GVDNYGivaudan SA-- -- $10.3B BCHMYBachem Holding AG-- -- $1.5B -
What do Analysts Say About GVDNY or BCHMY?
Givaudan SA has a consensus price target of --, signalling downside risk potential of --. On the other hand Bachem Holding AG has an analysts' consensus of -- which suggests that it could fall by --. Given that Givaudan SA has higher upside potential than Bachem Holding AG, analysts believe Givaudan SA is more attractive than Bachem Holding AG.
Company Buy Ratings Hold Ratings Sell Ratings GVDNYGivaudan SA0 0 0 BCHMYBachem Holding AG0 0 0 -
Is GVDNY or BCHMY More Risky?
Givaudan SA has a beta of 0.724, which suggesting that the stock is 27.563% less volatile than S&P 500. In comparison Bachem Holding AG has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock GVDNY or BCHMY?
Givaudan SA has a quarterly dividend of $1.50 per share corresponding to a yield of 1.71%. Bachem Holding AG offers a yield of 1.35% to investors and pays a quarterly dividend of $0.04 per share. Givaudan SA pays 69.09% of its earnings as a dividend. Bachem Holding AG pays out 50.27% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios GVDNY or BCHMY?
Givaudan SA quarterly revenues are --, which are smaller than Bachem Holding AG quarterly revenues of --. Givaudan SA's net income of -- is lower than Bachem Holding AG's net income of --. Notably, Givaudan SA's price-to-earnings ratio is 35.43x while Bachem Holding AG's PE ratio is 38.15x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Givaudan SA is 5.13x versus 7.52x for Bachem Holding AG. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GVDNYGivaudan SA5.13x 35.43x -- -- BCHMYBachem Holding AG7.52x 38.15x -- --
-
Which has Higher Returns GVDNY or CLZNY?
Clariant AG has a net margin of -- compared to Givaudan SA's net margin of --. Givaudan SA's return on equity of 24.76% beat Clariant AG's return on equity of 3.32%.
Company Gross Margin Earnings Per Share Invested Capital GVDNYGivaudan SA-- -- $10.3B CLZNYClariant AG-- -- $4.7B -
What do Analysts Say About GVDNY or CLZNY?
Givaudan SA has a consensus price target of --, signalling downside risk potential of --. On the other hand Clariant AG has an analysts' consensus of -- which suggests that it could fall by --. Given that Givaudan SA has higher upside potential than Clariant AG, analysts believe Givaudan SA is more attractive than Clariant AG.
Company Buy Ratings Hold Ratings Sell Ratings GVDNYGivaudan SA0 0 0 CLZNYClariant AG0 0 0 -
Is GVDNY or CLZNY More Risky?
Givaudan SA has a beta of 0.724, which suggesting that the stock is 27.563% less volatile than S&P 500. In comparison Clariant AG has a beta of 0.906, suggesting its less volatile than the S&P 500 by 9.441%.
-
Which is a Better Dividend Stock GVDNY or CLZNY?
Givaudan SA has a quarterly dividend of $1.50 per share corresponding to a yield of 1.71%. Clariant AG offers a yield of 3.8% to investors and pays a quarterly dividend of $0.47 per share. Givaudan SA pays 69.09% of its earnings as a dividend. Clariant AG pays out 102.99% of its earnings as a dividend. Givaudan SA's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Clariant AG's is not.
-
Which has Better Financial Ratios GVDNY or CLZNY?
Givaudan SA quarterly revenues are --, which are smaller than Clariant AG quarterly revenues of --. Givaudan SA's net income of -- is lower than Clariant AG's net income of --. Notably, Givaudan SA's price-to-earnings ratio is 35.43x while Clariant AG's PE ratio is 45.64x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Givaudan SA is 5.13x versus 0.88x for Clariant AG. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GVDNYGivaudan SA5.13x 35.43x -- -- CLZNYClariant AG0.88x 45.64x -- --
-
Which has Higher Returns GVDNY or EMSHF?
Ems-Chemie Holding AG has a net margin of -- compared to Givaudan SA's net margin of --. Givaudan SA's return on equity of 24.76% beat Ems-Chemie Holding AG's return on equity of 23.25%.
Company Gross Margin Earnings Per Share Invested Capital GVDNYGivaudan SA-- -- $10.3B EMSHFEms-Chemie Holding AG-- -- $2.3B -
What do Analysts Say About GVDNY or EMSHF?
Givaudan SA has a consensus price target of --, signalling downside risk potential of --. On the other hand Ems-Chemie Holding AG has an analysts' consensus of -- which suggests that it could fall by --. Given that Givaudan SA has higher upside potential than Ems-Chemie Holding AG, analysts believe Givaudan SA is more attractive than Ems-Chemie Holding AG.
Company Buy Ratings Hold Ratings Sell Ratings GVDNYGivaudan SA0 0 0 EMSHFEms-Chemie Holding AG0 0 0 -
Is GVDNY or EMSHF More Risky?
Givaudan SA has a beta of 0.724, which suggesting that the stock is 27.563% less volatile than S&P 500. In comparison Ems-Chemie Holding AG has a beta of 0.547, suggesting its less volatile than the S&P 500 by 45.347%.
-
Which is a Better Dividend Stock GVDNY or EMSHF?
Givaudan SA has a quarterly dividend of $1.50 per share corresponding to a yield of 1.71%. Ems-Chemie Holding AG offers a yield of 2.09% to investors and pays a quarterly dividend of $18.49 per share. Givaudan SA pays 69.09% of its earnings as a dividend. Ems-Chemie Holding AG pays out 102.23% of its earnings as a dividend. Givaudan SA's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Ems-Chemie Holding AG's is not.
-
Which has Better Financial Ratios GVDNY or EMSHF?
Givaudan SA quarterly revenues are --, which are smaller than Ems-Chemie Holding AG quarterly revenues of --. Givaudan SA's net income of -- is lower than Ems-Chemie Holding AG's net income of --. Notably, Givaudan SA's price-to-earnings ratio is 35.43x while Ems-Chemie Holding AG's PE ratio is 31.96x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Givaudan SA is 5.13x versus 7.04x for Ems-Chemie Holding AG. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GVDNYGivaudan SA5.13x 35.43x -- -- EMSHFEms-Chemie Holding AG7.04x 31.96x -- --
-
Which has Higher Returns GVDNY or HCMLY?
Holcim has a net margin of -- compared to Givaudan SA's net margin of --. Givaudan SA's return on equity of 24.76% beat Holcim's return on equity of 10.97%.
Company Gross Margin Earnings Per Share Invested Capital GVDNYGivaudan SA-- -- $10.3B HCMLYHolcim-- -- $30.1B -
What do Analysts Say About GVDNY or HCMLY?
Givaudan SA has a consensus price target of --, signalling downside risk potential of --. On the other hand Holcim has an analysts' consensus of -- which suggests that it could fall by --. Given that Givaudan SA has higher upside potential than Holcim, analysts believe Givaudan SA is more attractive than Holcim.
Company Buy Ratings Hold Ratings Sell Ratings GVDNYGivaudan SA0 0 0 HCMLYHolcim0 0 0 -
Is GVDNY or HCMLY More Risky?
Givaudan SA has a beta of 0.724, which suggesting that the stock is 27.563% less volatile than S&P 500. In comparison Holcim has a beta of 1.205, suggesting its more volatile than the S&P 500 by 20.507%.
-
Which is a Better Dividend Stock GVDNY or HCMLY?
Givaudan SA has a quarterly dividend of $1.50 per share corresponding to a yield of 1.71%. Holcim offers a yield of 3.21% to investors and pays a quarterly dividend of $0.62 per share. Givaudan SA pays 69.09% of its earnings as a dividend. Holcim pays out 46.21% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios GVDNY or HCMLY?
Givaudan SA quarterly revenues are --, which are smaller than Holcim quarterly revenues of --. Givaudan SA's net income of -- is lower than Holcim's net income of --. Notably, Givaudan SA's price-to-earnings ratio is 35.43x while Holcim's PE ratio is 16.15x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Givaudan SA is 5.13x versus 1.82x for Holcim. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GVDNYGivaudan SA5.13x 35.43x -- -- HCMLYHolcim1.82x 16.15x -- --
-
Which has Higher Returns GVDNY or SXYAY?
Sika AG has a net margin of -- compared to Givaudan SA's net margin of --. Givaudan SA's return on equity of 24.76% beat Sika AG's return on equity of 21.13%.
Company Gross Margin Earnings Per Share Invested Capital GVDNYGivaudan SA-- -- $10.3B SXYAYSika AG-- -- $13.8B -
What do Analysts Say About GVDNY or SXYAY?
Givaudan SA has a consensus price target of --, signalling downside risk potential of --. On the other hand Sika AG has an analysts' consensus of -- which suggests that it could fall by --. Given that Givaudan SA has higher upside potential than Sika AG, analysts believe Givaudan SA is more attractive than Sika AG.
Company Buy Ratings Hold Ratings Sell Ratings GVDNYGivaudan SA0 0 0 SXYAYSika AG0 0 0 -
Is GVDNY or SXYAY More Risky?
Givaudan SA has a beta of 0.724, which suggesting that the stock is 27.563% less volatile than S&P 500. In comparison Sika AG has a beta of 1.051, suggesting its more volatile than the S&P 500 by 5.098%.
-
Which is a Better Dividend Stock GVDNY or SXYAY?
Givaudan SA has a quarterly dividend of $1.50 per share corresponding to a yield of 1.71%. Sika AG offers a yield of 1.53% to investors and pays a quarterly dividend of $0.36 per share. Givaudan SA pays 69.09% of its earnings as a dividend. Sika AG pays out 46.36% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios GVDNY or SXYAY?
Givaudan SA quarterly revenues are --, which are smaller than Sika AG quarterly revenues of --. Givaudan SA's net income of -- is lower than Sika AG's net income of --. Notably, Givaudan SA's price-to-earnings ratio is 35.43x while Sika AG's PE ratio is 27.83x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Givaudan SA is 5.13x versus 2.93x for Sika AG. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GVDNYGivaudan SA5.13x 35.43x -- -- SXYAYSika AG2.93x 27.83x -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
